Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
143.1 USD | -1.94% | -1.53% | +21.10% |
May. 29 | BofA Securities Adjusts Crane Price Target to $165 From $140, Maintains Buy Rating | MT |
May. 27 | CR Double-Crane Pharmaceutical's Unit Gets Nod for Phloroglucinol Injection | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.10% | 8.34B | |
-19.35% | 12B | |
-8.94% | 6.41B | |
+45.53% | 2.08B | |
+3.00% | 1.59B | |
+17.74% | 904M | |
+6.61% | 901M | |
-6.88% | 647M | |
-12.78% | 622M | |
-25.21% | 391M |
- Stock Market
- Equities
- CR Stock
- News Crane Company
- China Includes CR Double-Crane Pharmaceutical's Two Drugs in List of Insurance-Backed Drugs